Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases.

Citation data:

Expert review of vaccines, ISSN: 1744-8395, Vol: 14, Issue: 1, Page: 21-35

Publication Year:
2015
Usage 193
Downloads 166
Clicks 13
Abstract Views 11
Link-outs 3
Captures 45
Readers 44
Exports-Saves 1
Mentions 1
Blog Mentions 1
Social Media 1
Tweets 1
Citations 10
Citation Indexes 10
Repository URL:
https://digitalcommons.uri.edu/immunology_facpubs/46; https://digitalcommons.uri.edu/cgi/viewcontent.cgi?article=1073&context=immunology_facpubs
PMID:
25193104
DOI:
10.1586/14760584.2015.955478
PMCID:
PMC4743591
Author(s):
Terry, Frances E; Moise, Leonard; Martin, Rebecca F; Torres, Melissa; Pilotte, Nils; Williams, Steven A; De Groot, Anne S
Publisher(s):
Informa UK Limited; DigitalCommons@URI; Informa Healthcare
Tags:
Immunology and Microbiology; Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics
Most Recent Tweet View All Tweets
Most Recent Blog Mention
review description
Vaccines have been invaluable for global health, saving lives and reducing healthcare costs, while also raising the quality of human life. However, newly emerging infectious diseases (EID) and more well-established tropical disease pathogens present complex challenges to vaccine developers; in particular, neglected tropical diseases, which are most prevalent among the world's poorest, include many pathogens with large sizes, multistage life cycles and a variety of nonhuman vectors. EID such as MERS-CoV and H7N9 are highly pathogenic for humans. For many of these pathogens, while their genomes are available, immune correlates of protection are currently unknown. These complexities make developing vaccines for EID and neglected tropical diseases all the more difficult. In this review, we describe the implementation of an immunoinformatics-driven approach to systematically search for key determinants of immunity in newly available genome sequence data and design vaccines. This approach holds promise for the development of 21st century vaccines, improving human health everywhere.